Evidano home
Commentary on News

AI Qualitative Analysis of Hepatitis C Barriers

Evidano8 min read

Public health researchers need to understand not only how many people face barriers to hepatitis C treatment, but also why those barriers delay care. The 2026 Los Angeles County study shows how mixed-methods research can combine program data with interviews to identify language, cost, transportation, provider, housing, and stigma-related obstacles. AI qualitative analysis of hepatitis C barriers can help research teams organize similar evidence across transcripts, reports, and survey responses while preserving the distinction between reported experiences and researcher interpretation. This article explains the study’s findings, shows how thematic analysis adds context to quantitative results, and maps the workflow to AI-enabled qualitative research. The discussion is research-focused and non-diagnostic.

Key Takeaways

The PLoS One study, “Exploring barriers and facilitators to Hepatitis C virus treatment access in Los Angeles County”, published on November 20, 2026, found that hepatitis C treatment access was shaped by personal, provider-related, insurance, language, transportation, and healthcare-navigation barriers.

AI qualitative analysis can help public health teams move from coded interview evidence to structured themes and cross-segment comparisons, but researchers must retain human review, participant privacy protections, and the study’s exploratory limitations.

  • According to the PLoS One study, 54% of 344 Los Angeles County case-residents contacted between October 2024 and January 2025 reported barriers to hepatitis C treatment.
  • According to the PLoS One study, personal barriers represented 43% of specific barriers, provider-related barriers represented 31%, insurance barriers represented 13%, and inadequate medical access represented 13% among respondents reporting specific barriers.
  • According to the PLoS One study, the qualitative sample included 10 interview participants, including 7 untreated participants and 3 treated participants, interviewed in English or Spanish between October 2024 and January 2025.
  • According to the PLoS One study, Los Angeles County recorded 27, 678 hepatitis C diagnoses between 2019 and 2023, while only 32% of people completed hepatitis C treatment.
  • According to the PLoS One study, reported facilitators included treatment motivation, family and community support, provider trust, adequate insurance, treatment knowledge, and the desire to avoid stigma.

What the 2026 Study Found About Hepatitis C Treatment Barriers

The 2026 PLoS One study used a convergent parallel mixed-methods design to compare de-identified program data with semi-structured interviews from Project HCV Connect in Los Angeles County. The quantitative analysis described the prevalence and categories of reported barriers, while the qualitative analysis explored how those barriers affected treatment decisions.

The PLoS One researchers analyzed program data from 344 case-residents contacted between October 2024 and January 2025. The study reported that 168 people, or 49%, had already received treatment, while 176 people had not received treatment.

The PLoS One researchers conducted thematic analysis of 10 interviews, including 7 untreated participants and 3 treated participants. The researchers coded transcripts iteratively, compared codes collaboratively, and resolved coding discrepancies through team discussion.

The interviews added context that the numerical categories alone could not provide. Untreated participants described cost, language barriers, transportation, limited hepatitis C information, and difficulty navigating the healthcare system. Treated participants described homelessness, incarceration, drug addiction, and long waits for specialist care.

One untreated Spanish-speaking participant told the PLoS One researchers, “I didn’t understand very well what they were telling me.” The quote illustrates why language access is not simply a demographic variable, but a pathway through which communication can affect treatment engagement.

The study also identified facilitators that can inform intervention design. One untreated Spanish-speaking participant said, “I think it is good to seek treatment, ” while treated participants described family support, provider trust, insurance coverage, improved quality of life, and reduced stigma as reasons for moving through care.

Findings Snapshot: Numbers Behind the Qualitative Themes

Date or periodMeasureValueResearch implication
October 2024 to January 2025Los Angeles County case-residents contacted344The program data supplied the quantitative context for the interview themes, according to the 2026 PLoS One study.
October 2024 to January 2025Case-residents reporting treatment barriers54%More than half of the program population reported at least one barrier, according to the 2026 PLoS One study.
October 2024 to January 2025Interview participants10 total, 7 untreated and 3 treatedThe qualitative evidence provided detailed explanations but was exploratory and not broadly generalizable, according to the 2026 PLoS One study.
2019 to 2023People diagnosed with hepatitis C in Los Angeles County27, 678The scale of diagnosis created a substantial need for linkage-to-treatment research, according to the 2026 PLoS One study.
2019 to 2023Reported hepatitis C treatment completion32%Low completion reinforced the need to investigate barriers beyond diagnosis, according to the 2026 PLoS One study.

Implications for Public Health and Qualitative Research Teams

Public health teams should analyze treatment access as a connected system of individual, provider, insurance, language, and structural factors. The 2026 PLoS One study specifically recommended language support, patient navigation, care coordination, mobile clinics for people experiencing homelessness, continuity of treatment after incarceration, and fewer insurance restrictions.

Qualitative researchers should preserve differences between participant segments instead of collapsing all barriers into a single theme. The PLoS One study compared treated and untreated participants and examined English-speaking and Spanish-speaking experiences, which revealed different needs for provider guidance, health information, and system navigation.

AI-enabled qualitative analysis is most useful when it accelerates organization without replacing interpretation. Researchers can use AI to identify recurring concepts such as cost, transportation, trust, stigma, or language, then inspect supporting excerpts and compare patterns by treatment status, language, insurance, or housing context.

The PLoS One study reported that its quantitative subcategories were often smaller than 15 observations, so the researchers limited the quantitative analysis to descriptive statistics. AI-generated patterns should therefore be treated as evidence for review, not as proof of causal relationships or population-wide disparities.

Healthcare research teams must also protect sensitive participant information. The PLoS One researchers de-identified interview data and obtained institutional review board approval from the University of Southern California before conducting the interviews.

How Evidano Supports AI Qualitative Analysis of Hepatitis C Barriers

Problem: Interview transcripts contain overlapping barriers and facilitators

Evidano is an AI-powered qualitative data analysis platform that helps researchers analyze interviews, open-ended surveys, and documents.

Evidano can support thematic, content, frequency, and cross-segment analyses across interview transcripts and research documents. A public health team could organize themes such as language access, cost, provider trust, transportation, stigma, and family support, then compare those themes across treated and untreated participants.

Researchers can review the underlying excerpts before using a theme in a report, keeping the interpretation connected to participant evidence. Teams can learn more about the platform through Evidano’s qualitative research features.

Problem: Multilingual interviews make comparison difficult

The PLoS One study collected interviews in English and Spanish, so translation and language-aware review are important parts of a comparable analysis workflow.

Evidano provides transcription and translation capabilities that can help teams prepare multilingual qualitative data for analysis. Researchers should preserve the original-language transcript and verify translated excerpts before publication.

Problem: Researchers need fast answers across a mixed evidence base

The 2026 PLoS One study combined program data, interview transcripts, and prior evidence to interpret treatment access barriers.

Evidano’s AI chat can help researchers ask focused questions across uploaded documents and analyses, such as which barriers recur across participant groups or which facilitators are associated with treatment engagement. Researchers should treat generated answers as reviewable research support rather than an independent substitute for methodological judgment.

Problem: Sensitive health narratives require careful data handling

The PLoS One study used de-identified data and removed identifying information from interview materials before analysis.

Evidano offers PII redaction, encryption, and a policy that customer data is not used to train third-party models. Research teams should still follow their institutional review board requirements, consent terms, access controls, and data-retention policies.

FAQ: AI Qualitative Analysis of Hepatitis C Barriers

What were the main hepatitis C treatment barriers in Los Angeles County?

The main barriers were personal, provider-related, insurance-related, and healthcare-access barriers, according to the 2026 PLoS One study.

Interview participants added language barriers, cost, transportation, limited treatment information, homelessness, incarceration, drug addiction, long waits, and difficulty navigating the healthcare system.

How many people were included in the Los Angeles County hepatitis C study?

The study included de-identified program data from 344 case-residents and qualitative interviews with 10 participants, according to the 2026 PLoS One study.

The interview sample included 7 untreated participants and 3 treated participants, so the qualitative findings were exploratory rather than representative of all Los Angeles County residents.

How can AI help analyze hepatitis C treatment interviews?

AI can help researchers organize transcripts, identify candidate themes, compare participant segments, count coded content, and retrieve supporting excerpts.

Human researchers must validate codes, review context, protect participant confidentiality, and avoid treating automated patterns as causal findings. The 2026 PLoS One study’s small qualitative sample and descriptive quantitative design make those safeguards especially important.

What facilitators helped people access hepatitis C treatment?

The main facilitators were personal motivation, family and community support, provider trust, adequate insurance, understanding treatment benefits, and the desire to avoid stigma, according to the 2026 PLoS One study.

The study recommended using these facilitators in patient education, outreach, navigation, and care-coordination strategies.

Can AI qualitative analysis replace public health researchers?

AI qualitative analysis cannot replace public health researchers because interpretation requires methodological judgment, contextual knowledge, ethical oversight, and accountability.

AI tools can reduce manual organization time, but researchers must verify excerpts, assess alternative explanations, document analytic decisions, and report limitations.

Conclusion and Next Steps for AI-Enabled Health Research

The 2026 PLoS One study demonstrates why hepatitis C treatment access requires both quantitative measurement and qualitative explanation. The study’s 344-person program dataset showed the scale of reported barriers, while 10 interviews revealed how language, cost, trust, information, housing, and healthcare navigation shaped treatment journeys.

AI qualitative analysis can help public health and healthcare research teams process multilingual interviews and mixed evidence more consistently, provided that researchers retain human review and protect sensitive data. Evidano connects thematic, frequency, and cross-segment analysis with document-based AI support for this workflow.

Teams can try Evidano for free to organize qualitative health research and turn interview evidence into defensible, reviewable findings.

Topics

  • AI qualitative analysis of hepatitis C barriers
  • hepatitis C treatment barriers
  • AI thematic analysis in public health
  • mixed-methods qualitative research
  • qualitative health research software

Keep reading

Browse all articles